Results 231 to 240 of about 21,032 (282)

Psoralens

Archives of Dermatology, 1986
For more than a decade, psoralen plus long-wave ultraviolet-A irradiation (PUVA) has been used extensively to treat psoriasis. 1,2 During this time, crystalline methoxsalen (8-methoxypsoralen [8-MOP]) has been the principle oral psoralen available for PUVA therapy in the United States and is currently the only 8-MOP formulation approved by the Food and
openaire   +1 more source

Psoralens

Reactions Weekly, 2007
  +5 more sources

Psoralen Phototherapeutic Agents

JAMA: The Journal of the American Medical Association, 1967
Photosensitizers have been used in medicine for several thousand years. In the past, the effect being sought was repigmentation of light areas in the skin. Most of the orally administered or locally applied preparations were obtained from plants that contain psoralen (furocoumarin).
openaire   +2 more sources

Psoralen and Photoactivation

Annals of Internal Medicine, 1980
Excerpt To the editor: The valuable article by Perlman and colleagues, "Photochemotherapy and Psoriatic Arthritis: A Prospective Study" (1), successfully shows that nonspondylitic psoriatic arthrit...
openaire   +2 more sources

Psoralen Photobiology: Recent Advances

Photochemistry and Photobiology, 1996
Clinical efficacy may arise from psoralen-induced photodamage by the induction of a panoply of biomolecules. In cellular studies with UV or photoactivatable agents, the activation of NF-kappa B, probably the most widely studied transcription factor, occurs after its release from an inhibiting factor, I kappa B.
openaire   +2 more sources

PSORALEN PHOTOCHEMISTRY

Photochemistry and Photobiology, 1980
openaire   +2 more sources

PSORALEN PHOTOCHEMISTRY

Annual Review of Biophysics and Bioengineering, 1981
openaire   +2 more sources

Psoralens

BMJ, 1977
  +5 more sources

Psoralen photochemotherapy

Journal of the American Academy of Dermatology, 1980
openaire   +2 more sources

Psoralens

Reactions, 1988
openaire   +2 more sources